Purpose: To determine the value of prostatic length as a predictor of urinary morbidity after brachytherapy for prostate cancer.
Methods And Materials: Between May 2002 and September 2008, 214 consecutive patients received brachytherapy for localized prostate cancer at our institution. A prospective analysis of factors predicting urinary toxicity was carried out for these patients.